Načítá se...

Biomarkers in the Assessment of Therapies for Familial Amyloidotic Polyneuropathy

The identification of specific biomarkers provides opportunities to develop early diagnostic parameters, monitor disease progression, and test drug efficiency in clinical trials. We previously demonstrated that in familial amyloidotic polyneuropathy (FAP) related to the abnormal extracellular tissue...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Macedo, Bárbara, Batista, Ana Rita, do Amaral, José Barbas, Saraiva, Maria João
Médium: Artigo
Jazyk:Inglês
Vydáno: ScholarOne 2007
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2017105/
https://ncbi.nlm.nih.gov/pubmed/17932549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/2007-00068.Macedo
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!